scholarly article | Q13442814 |
meta-analysis | Q815382 |
P356 | DOI | 10.1192/BJP.BP.114.160242 |
P698 | PubMed publication ID | 27103682 |
P50 | author | Brian Hallahan | Q42856863 |
Joseph R Hibbeln | Q89137357 | ||
Christopher E Ramsden | Q96192437 | ||
John M. Davis | Q96192440 | ||
John Paul SanGiovanni | Q114678175 | ||
P2093 | author name string | Timothy Ryan | |
Ivan T Murray | |||
Shauna Glynn | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | fatty acid | Q61476 |
P1104 | number of pages | 10 | |
P304 | page(s) | 192-201 | |
P577 | publication date | 2016-04-21 | |
P1433 | published in | British Journal of Psychiatry | Q4035428 |
P1476 | title | Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression | |
P478 | volume | 209 |
Q101121007 | Acute EPA-induced learning and memory impairment in mice is prevented by DHA |
Q47761010 | Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial |
Q57276197 | Association of Use of Omega-3 Polyunsaturated Fatty Acids With Changes in Severity of Anxiety Symptoms |
Q49388642 | Bioefficacy potential of different genotypes of walnut Juglans regia L. |
Q47319941 | Blood fatty acid changes in healthy young Americans in response to a 10-week diet that increased n-3 and reduced n-6 fatty acid consumption: a randomised controlled trial |
Q92430456 | Complementary therapies for clinical depression: an overview of systematic reviews |
Q47557624 | Diet, nutrition and the ageing brain: current evidence and new directions |
Q42257132 | Dietary fish, n-3 polyunsaturated fatty acid consumption, and depression risk in Japan: a population-based prospective cohort study. |
Q50247505 | Dietary polyunsaturated fatty acids, brain function and mental health. |
Q47569143 | Effects of eicosapentaenoic acid and docosahexaenoic acid on anxiety-like behavior in socially isolated rats |
Q92431544 | Efficacy of omega-3 PUFAs in depression: A meta-analysis |
Q40963212 | Emulsified omega-3 fatty-acids modulate the symptoms of depressive disorder in children and adolescents: a pilot study. |
Q64107255 | Evaluation of the effect of insulin sensitivity-enhancing lifestyle- and dietary-related adjuncts on antidepressant treatment response: protocol for a systematic review and meta-analysis |
Q40230630 | Food Insecurity and Depression Among Adults With Diabetes: Results From the National Health and Nutrition Examination Survey (NHANES). |
Q58799131 | Food for Mood: Relevance of Nutritional Omega-3 Fatty Acids for Depression and Anxiety |
Q58122230 | Lipidomics in Major Depressive Disorder |
Q60441607 | Lipids and polyunsaturated fatty acid levels in deliberate self-harm: a 10-year follow-up study |
Q102053954 | Low Omega-3 intake is associated with high rates of depression and preterm birth on the country level |
Q39471285 | Metabolic fate of docosahexaenoic acid (DHA; 22:6n-3) in human cells: direct retroconversion of DHA to eicosapentaenoic acid (20:5n-3) dominates over elongation to tetracosahexaenoic acid (24:6n-3). |
Q96172053 | N-3 polyunsaturated fatty acids promote astrocyte differentiation and neurotrophin production independent of cAMP in patient-derived neural stem cells |
Q38873290 | Novel biotherapies are needed in youth mental health. |
Q47221225 | Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic and Environmental Risk Factors from Cell to Humans |
Q91893886 | Omega-3 Fatty Acids as a Treatment for Pediatric Depression. A Phase III, 36 Weeks, Multi-Center, Double-Blind, Placebo-Controlled Randomized Superiority Study |
Q48340591 | Omega-3 Supplementation and the Neural Correlates of Negative Affect and Impulsivity: A Double-Blind, Randomized, Placebo-Controlled Trial in Midlife Adults |
Q90169497 | Omega-3 fatty acids for the treatment of depressive disorders in children and adolescents: a meta-analysis of randomized placebo-controlled trials |
Q33785212 | Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial. |
Q38604033 | Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study |
Q90737002 | Quantitation of Human Whole-Body Synthesis-Secretion Rates of Docosahexaenoic Acid and Eicosapentaenoate Acid from Circulating Unesterified α-Linolenic Acid at Steady State |
Q90464891 | Relationship between Diet and Mental Health in a Young Adult Appalachian College Population |
Q61806045 | Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders |
Q64327441 | Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD) |
Q93181443 | The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials |
Search more.